SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹6.65 Cr | ₹6.04 Cr | ₹7.16 Cr | ₹6.39 Cr | ₹13 Cr |
What is the latest Total Non-Current Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹6.65 Cr |
| Mar2024 | ₹6.04 Cr |
| Mar2023 | ₹7.16 Cr |
| Mar2022 | ₹6.39 Cr |
| Mar2021 | ₹13 Cr |
How is Total Non-Current Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.65 Cr | 10.03 | |
| Mar2024 | ₹6.04 Cr | -15.63 | |
| Mar2023 | ₹7.16 Cr | 12.18 | |
| Mar2022 | ₹6.39 Cr | -50.78 | |
| Mar2021 | ₹13 Cr | - | |
Compare Total Non-Current Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹2,377.7 Cr | 1.6% | 30.8% | 97.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 1.6% |
30.8% |
97.9% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses